Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03763565Completed

Effectiveness of HPV Vaccine in Thai Adult Women

Role: collaborator

NCT05313074Not ApplicableCompleted

SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients

Role: lead

NCT01906112Phase 3Withdrawn

Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.

Role: lead

NCT01943032Completed

Discordant Hormonal Status of Breast Cancer.

Role: lead

NCT01935739Completed

Discordant HER2/Neu Status of Breast Cancer.

Role: lead

All 5 trials loaded